Healx Logo

Healx Blog - Healx

Healx Blog

Healx and Muscular Dystrophy UK join forces to find new treatments for rare muscle-wasting diseases

Cambridge UK – 15 July 2020 – Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, today announced its Rare Treatment Accelerator Programme (RTA) partnership with Muscular Dystrophy UK (MDUK). The RTA collaboration will initially focus on finding novel therapies for facioscapulohumeral muscular dystrophy (FSHD) – a … Continued

Webinar | How to Develop In Vivo Models for Rare Disease Research

This webinar is suitable for patient groups at the beginning of their journey to create in vivo models to accelerate the research and development of novel treatments for their rare disease of interest. During this 60-minute session our speakers discuss how to successfully create and validate animal models for preclinical drug testing – from both … Continued

Meri Williams joins Healx as Chief Technology Officer

Cambridge, UK – 17 June, 2020. Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, is proud to announce that Meri Williams has joined its senior leadership team as Chief Technology Officer.  Meri joins from challenger bank Monzo, where she helped scale the engineering and data team … Continued

Healx partners with Children’s Tumor Foundation to progress neurofibromatosis treatments; recruits patient advocate to lead collaborative drug discovery efforts

Cambridge UK – 15 April 2020 – Healx, the AI-powered and patient-inspired tech company specialising in accelerating the discovery and development of rare disease treatments, today announced a partnership with US and Europe-based patient group Children’s Tumor Foundation (CTF) to progress new AI-derived therapies for neurofibromatosis (NF). NF is a rare genetic disorder that affects … Continued